Different policies on prenatal ultrasound screening programmes and induced abortions explain regional variations in

E Garne1, A Berghold, Z Johnson

  • 1University of Southern Denmark, Odense, Denmark. EGarne@dadlnet.dk

Insights

Induced abortions (IA) and prenatal screening impact infant mortality from congenital malformations. Policies significantly affect outcomes, with screening altering the timing of death rather than overall mortality rates.

Area of Science:

  • Perinatal epidemiology
  • Public health policy
  • Medical genetics

Background:

  • Congenital malformations contribute significantly to infant mortality.
  • Regional variations in induced abortion (IA) policies and prenatal screening exist across Europe.
  • Understanding the interplay of these factors is crucial for public health strategies.

Purpose of the Study:

  • To compare the impact of induced abortions (IA) on infant mortality with congenital malformations.
  • To analyze regional differences in IA policies and prenatal ultrasound screening.
  • To assess the effect of these policies on mortality rates in four European regions.

Main Methods:

  • Registry-based data collection on congenital malformations.
  • Inclusion of data from Ireland (Dublin), Denmark (Funen County), Austria (Styria), and France (Strasbourg).
  • Statistical analysis of IA, fetal deaths, and infant deaths with congenital malformations.

Main Results:

  • Infant deaths with malformations ranged from 23% to 44% of all infant deaths.
  • Dublin, with no IA and no screening, had the highest proportion of infant deaths with malformations.
  • Significant regional differences were observed in IA, fetal deaths, and infant deaths (p < 0.001).

Conclusions:

  • Prenatal ultrasound screening has a minor impact on total mortality from the second trimester to one year of age.
  • Screening appears to alter the timing of death for infants with congenital malformations.
  • These timing shifts have implications for parental bereavement and community support.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...